Inventor
JØRGENSEN MORTEN
DK14 patents
⚠️ This page may combine multiple inventors who share the name “JØRGENSEN MORTEN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
H LUNDBECK AS
13 patentsUS11707476B2Jul 25, 2023
Catecholamine prodrugs for use in the treatment of parkinson's disease
H LUNDBECK AS12 citations93
US11110110B2Sep 7, 2021
Catecholamine prodrugs for use in the treatment of Parkinson's disease
H LUNDBECK AS15 citations93
US10729710B2Aug 4, 2020
Catecholamine prodrugs for use in the treatment of Parkinson's disease
H LUNDBECK AS21 citations93
US11130775B2Sep 28, 2021
Solid forms of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid
H LUNDBECK AS14 citations92
US12226428B2Feb 18, 2025
Catecholamine prodrugs for use in the treatment of Parkinson's disease
H LUNDBECK AS6 citations85
US11858954B2Jan 2, 2024
Solid forms of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4AR,10AR)-7-hydroxy-1-propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid
H LUNDBECK AS8 citations83
US12421271B2Sep 23, 2025
Solid forms of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4AR, 10AR)-7-hydroxy-1-propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid
H LUNDBECK AS0 citations61
US12071416B2Aug 27, 2024
Prodrugs of 4-( (1R, 3S)-6-chloro-3-phenyl-2, 3-dihydro-1H-inden-1-yl)-1,2, 2-trimethylpiperazine and 4-( (1R, 3S)-6-chloro-3-(phenyl-D5)-2, 3-dihydro-1H-inden-1-yl)-2, 2-dimethyl-1 (methyl-D3) piperazine
H LUNDBECK AS0 citations61
US11535600B2Dec 27, 2022
Prodrugs of 4-((1R,3S)-6-chloro-3-phenyl-2,3-dihydro-1H-inden-1-yl)-1,2,2-trimethylpiperazine and 4-((1R,3S)-6-chloro-3-(phenyl-d5)-2,3-dihydro-1H-inden-1-yl)-2,2-dimethyl-1-(methyl-d3)piperazine
H LUNDBECK AS1 citations61
US12398106B2Aug 26, 2025
Catecholamine carbamate prodrugs for use in the treatment of parkinson's disease
H LUNDBECK AS0 citations52
US12384765B2Aug 12, 2025
Catecholamine prodrugs for use in the treatment of Parkinson's Disease
H LUNDBECK AS0 citations51
US12319710B2Jun 3, 2025
Catecholamine prodrugs for use in the treatment of Parkinson's diseases
H LUNDBECK AS0 citations51
US12391650B2Aug 19, 2025
Catecholamine prodrugs for use in the treatment of Parkinson's disease
H LUNDBECK AS0 citations50